Zynexの将来のP / E
Zynexの将来のP / Eは何ですか。
Zynex, Inc.の将来のP / Eは26.18です。
将来のP / Eの定義は何ですか。
未来比率P / E (株価収益率)は、企業の株価と今後12ヶ月間の1株当たり利益見込額との比率です。
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
TSXのセクタHealth Careにおける将来のP / Eの企業と比べるZynex
Zynexは何をしますか。
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES) device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. The company also supplies electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products; and distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers CM-1500, a blood volume monitor device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.
Zynexと類似の将来のp / e
- Maxar Technologiesの将来のP / Eは26.11です。
- Vgp Nvの将来のP / Eは26.11です。
- Danaherの将来のP / Eは26.11です。
- J. B. Chemicals & Pharmaceuticalsの将来のP / Eは26.11です。
- ELANTAS Beck Indiaの将来のP / Eは26.11です。
- Dycom Industriesの将来のP / Eは26.14です。
- Zynexの将来のP / Eは26.18です。
- MarketAxessの将来のP / Eは26.21です。
- Delta 9 Cannabisの将来のP / Eは26.25です。
- Green Impact Partnersの将来のP / Eは26.25です。
- Scout24 AGの将来のP / Eは26.25です。
- Andlauer Healthcareの将来のP / Eは26.25です。
- Qualys Incの将来のP / Eは26.26です。